The Rottenstein Law Group, which represents clients with claims stemming from injuries allegedly caused by drugs in the selective serotonin reuptake inhibitor (SSRI) class of antidepressants, is helping to make the public aware of the results of a recent study finding that use of SSRIs might confer a small but statistically significant risk of brain hemorrhage.
(PRWeb October 18, 2012)
Read the full story at http://www.prweb.com/releases/2012/10/prweb10032773.htm
